Starna Therapeutics
PrivateLast Round
Series B
Oct 22, 2025
Total Funding Raised
$66.1M
Momentum Score
25 /100
Company Overview
Starna Therapeutics is a biotechnology company that develops innovative RNA-based drugs and vaccines using its proprietary extrahepatic targeted delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starna Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Starna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 22, 2025 | ||||
| Series A | May 16, 2022 |
Starna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Primavera Venture Partners | Series A |
| Hillhouse Investment | Series B |
| LYFE Capital | Series A, Series B |
| GL Ventures | Series A |
| Hony Capital | Series A |
| Source Code Capital | Series A |
| Lilly Asia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
$44M round completed.
Starna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Starna Therapeutics's valuation, stock price, and market status.
